COVID-19 Vaccination Likely Cause of Man’s Acquired Hemophilia A
COVID-19 vaccines, because they work to stimulate the immune system, may be an emerging cause of autoimmune conditions like…
Articles by Lindsey Shapiro, PhD
Positive Early Results of Mim8 Pave Way for Testing in Phase 3 Trials
Mim8, an investigational therapy to prevent bleeding episodes in people with hemophilia A, is safe and well-tolerated at multiple…
Antibodies in Some Hem B Patients May Make Gene Therapy Not Work
Nearly one-third of people with hemophilia B have antibodies against a subtype of an adeno-associated virus (AAV) — called…
Roctavian Recommended for Use in EU as 1st Gene Therapy for Hem A
European authorities have recommended conditional marketing authorization for Roctavian (valoctocogene roxaparvovec), BioMarin Pharmaceutical’s one-time gene therapy for adults with severe…
Low-dose Preventive Therapy Yields Variable FVIII Levels, Study Reports
Preventive treatment with a low dose of factor replacement therapy in children with hemophilia A led to sufficient levels…
Anxiety, Depression Need Better Management in Hemophilia: Survey
Symptoms of pain, anxiety, and depression generally increased with disease severity in people with hemophilia and were also associated with…
CSL Behring Donating 500M Units of Factor Therapy to WFH Aid Program
CSL Behring will donate 500 million international units (IUs) of coagulation factor therapy to the World Federation of…
2 Diagnosed With Mild Hemophilia A Due to Bleeds After Oral Surgery
Excessive bleeding after oral surgery led to two people in China, both with normal pre-operative blood clotting tests, being diagnosed…
Ankle Joint Damage in Hemophilia Common, But Not Linked to Pain
Structural joint damage and significant pain are evident in the ankles of people with hemophilia, but the two were…